Biopharma | April 14, 2026
Gennova CEO Dr Sanjay Singh sees strong innovation momentum for India’s biopharma sector
Veteran biopharma leader stressed that generic medicines must be viewed separately from biologics
Veteran biopharma leader stressed that generic medicines must be viewed separately from biologics
The enhanced allocation will be directed toward expanding healthcare infrastructure, increasing patient capacity, and widening acces
The dual expansion simplifies transcriptomics workflows by combining faster regional turnaround with easier sample logistics
Punya Salila Srivastava commends sanitation, waste management and infection control measures, while inaugurating a new G+9 undergraduate girls’ hostel
The collaboration promises expanded funding for Thai universities, research institutes, companies, and global research partners working in Thailand
New filtration lines will boost global drug supply and strengthen India’s role in Merck’s manufacturing network
Samsung Biologics will continue supplying products previously manufactured at the site to GSK
Phase I to supply clean energy to five facilities, with long-term plans to power 19 hospitals through a 30 MW renewable network
Minister highlights scope for domestic manufacturing during his meeting with Dr Niti Pall, President-elect, International Diabetes Federation
Ac-225, an alpha-emitting radionuclide, can be paired with molecules designed to selectively target cancer cells.
Subscribe To Our Newsletter & Stay Updated
